Onlymyhealth1d
Ageing and Vision: Expert Explains How Our Eyes Change As We Age
Our vision declines as we age leading to the development of various eye conditions such as presbyopia cataracts and glaucoma ...
A Patient’s Guide to Macular Degeneration: Symptoms and Treatment
Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...
Optician's warning to 'stop habit' or risk rising 'silent killer'
Tina Patel, contact lens optician at Feel Good Contacts, has warned smokers around the UK, with AMD currently affecting more ...
Le Lézard2d
Astellas Submits New Drug Application for Conditional Approval of Avacincaptad Pegol for Geographic Atrophy in Japan
Astellas Pharma Inc. (TSE: 4503) (President and CEO: Naoki Okamura, "Astellas") today announced the submission of a New Drug Application (NDA) to Japan's Ministry of Health, Labour and Welfare (MHLW) ...
With FDA approval, Genentech turns eye implant's focus to diabetes
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Hosted on MSN2d
Judi Dench Talks Fading Eyesight-She Can't Walk Alone or ‘I Will Fall Over'
From her Oscar-winning turn as Queen Elizabeth I in Shakespeare in Love to her famously gender-swapped role as "M" in the ...
Business Wire2d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Managed Healthcare Executive2d
FDA Approves Susvimo for Diabetic Macular Edema
Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...
Taiwan News3d
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME) With as few as two treatments per year, Susvimo ...
Thought Leadership & Innovation Foundation (TLI) Initiatives Raise Awareness of Age-related Macular Degeneration (AMD) and Low Vision
MCLEAN, Va., Feb. 04, 2025 (GLOBE NEWSWIRE) -- (TLI), a not-for-profit organization that works at the nexus of science, ...
Serious eye disease Age-Related Macular Degeneration (AMD) recognized with official awareness month: Canadian Ophthalmological Society
The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...